Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR/ALK wild-type advanced non-small cell lung cancer

BACKGROUND: Immunotherapy has become an important treatment option for patients with advanced non-small cell lung cancer (NSCLC). At present, none of these existing biomarkers can effectively stratify true responders and there is an urgent need for identifying novel biomarkers. Exosomes derived from...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Xiao-Xiao, Yu, Ruoying, Wu, Xue, Wu, Shu-Yu, Pi, Can, Chen, Zhi-Hong, Zhang, Xu-Chao, Gao, Cun-Yi, Shao, Yang W, Liu, Li, Wu, Yi-Long, Zhou, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057418/
https://www.ncbi.nlm.nih.gov/pubmed/31959728
http://dx.doi.org/10.1136/jitc-2019-000376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057418/
https://www.ncbi.nlm.nih.gov/pubmed/31959728
http://dx.doi.org/10.1136/jitc-2019-000376

Ejemplares similares